February 2022 — Pharma News Archive

Every regulatory action (135), Phase 3 readout (0), and patent expiry (0) tracked in February 2022. Sourced from Drugs@FDA, EMA EPAR, ClinicalTrials.gov, USPTO Orange Book.

135 regulatory actions 0 Phase 3 readouts 0 patent expiries

Regulatory actions (135)

Phase 3 trial readouts (0)

No Phase 3 readouts tracked in this month.

Patent expiries (0)

No patent expiries tracked in this month.

Subscribe to ongoing alerts

This page is a permanent monthly archive. For ongoing alerts as new events happen:

See also